SEC Filings
Blackstone Affiliate Holds 7.6% Of Autolus After Warrants Expire
BXLS V - Autobahn's ownership update came from expired warrants, rather than buying or selling shares.
AUTL
Autolus Therapeutics (AUTL) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
Autolus Stock Sinks 5% After Earnings — Its Multiple-Sclerosis Data Presentation Moves Further Out
AUCATZYL sales rose 95%, and Autolus expects annual sales to meet or exceed $150 million, the top of its previous forecast.
Earnings
Autolus Moves MS Data To October 2027 — Its CEO Says Earlier Results Wouldn't Guide Development
Analysts challenged the longer wait and larger trial as Autolus raised its leukemia therapy sales outlook to at least $150 million.
SEC Filings
Autolus AUCATZYL Sales Surge 95% — Its Annual Outlook Now Reaches The Former Ceiling
Manufacturing margins improved, but the company moved its first multiple-sclerosis data presentation to October 2027.